Trikafta 37.5 mg

TRIKAFTA 37.5 MG tablets contain ivacaftor, a medication used to treat certain genetic conditions. This oral medication is designed to help manage symptoms associated with specific mutations.

TRIKAFTA 37.5 MG tablets are primarily used to treat cystic fibrosis in patients with specific genetic mutations. This medication works by improving the function of a protein that regulates chloride transport in cells. What is TRIKAFTA used for? It is often prescribed to help manage symptoms and improve lung function in individuals with cystic fibrosis.

Common effects of TRIKAFTA 37.5 MG tablets may include headaches, stomach pain, and dizziness. Some users may also experience changes in liver function, so regular monitoring is recommended. Always consult a healthcare provider for personalized advice.

TRIKAFTA 37.5 MG tablets should be used with caution in patients with liver problems. It is important to follow the prescribed dosage and monitor liver function regularly. Avoid grapefruit and grapefruit juice, as they can interact with ivacaftor.

TRIKAFTA 37.5 MG tablets may interact with certain medications, including some antibiotics and antifungals. Alcohol and other substances that affect liver function should be avoided. Always inform your healthcare provider about all medications you are taking.